A randomized, double‐blind, placebo‐controlled, multicenter, parallel‐group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial‐onset seizures-Reference-Cited by-同舟云学术

A randomized, double‐blind, placebo‐controlled, multicenter, parallel‐group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial‐onset seizures

Published:2015-10-16 Issue:12 Volume:56 Page:1890-1898
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Klein Pavel¹,Schiemann Jimmy²,Sperling Michael R.³,Whitesides John²,Liang Wei²,Stalvey Tracy²,Brandt Christian⁴^ORCID,Kwan Patrick⁵⁶

Affiliation:

1. Mid‐Atlantic Epilepsy and Sleep Center Bethesda Maryland U.S.A

2. UCB Pharma Raleigh North Carolina U.S.A

3. Thomas Jefferson University Philadelphia Pennsylvania U.S.A

4. Bethel Epilepsy Centre Mara Hospital Bielefeld Germany

5. University of Melbourne and Royal Melbourne Hospital Parkville Victoria Australia

6. Chinese University of Hong Kong Hong Kong Hong Kong SAR China

Funder

Eisai

GlaxoSmithKline

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/epi.13212

Reference19 articles.

1. Estimation of the burden of active and life-time epilepsy: A meta-analytic approach

2. Patterns of treatment response in newly diagnosed epilepsy

3. Early Identification of Refractory Epilepsy

4. Newer drugs for focal epilepsy in adults

5. Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemma

Cited by 199 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Romanian Translation and Cultural Adaptation of the Seizure Severity Questionnaire;Neurology International;2024-09-13

2. Demonstration of Group-Level and Individual-Level Efficacy Using Time-to-Event Designs for Clinical Trials of Antiseizure Medications;Neurology;2024-08-27

3. Impact of Third-Generation Antiseizure Medications on People with Epilepsy in a Low-Income Population: The Brivaracetam Experience in a Real-World Study;Drugs - Real World Outcomes;2024-07-23

4. A prospective, observational, multicentre study to evaluate the efficacy of brivaracetam as adjuvant therapy for epilepsy: The Bravo study;Drugs in Context;2024-07-08

5. Time-course of drug-related psychiatric and behavioral treatment-emergent adverse events during brivaracetam treatment in adults with focal-onset seizures;Epilepsy & Behavior;2024-07